{
    "nctId": "NCT04522648",
    "briefTitle": "Prospective Surveillance for Breast Cancer-Related Lymphedema",
    "officialTitle": "Prospective Surveillance for Breast Cancer-Related Lymphedema: A Randomized Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 250,
    "primaryOutcomeMeasure": "Prevalence of chronic lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* female;\n* \u226518 years;\n* surgery for breast cancer (unilateral and bilateral) including ALDN with \\>6 lymph nodes removed;\n* can effectively communicate verbally in Danish;\n\nExclusion Criteria:\n\n* surgery for breast cancer with SLNB or \\< 6 nodes removed;\n* pre-existing lymphedema (primary or secondary);\n* previous treatment for breast cancer;\n* pace maker;\n* conditions known to cause swelling (pregnancy, congestive heart failure, chronic/acute renal disease, cor pulmonale, nephrotic syndrome, nephrosis, liver failure or cirrhosis, pulmonary edema, and thrombophlebitis or deep vein thrombosis in the arms).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}